HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Infectious Disease
Technical report validates AI tool for classifying MPXV subclades using genomic data
New AI tool quickly identifies dangerous mpox virus types from DNA samples
This technical report describes a methodological development for a software tool called CladePredictor-MPXV. The authors evaluated classific…
This new AI tool sorts mpox virus types in seconds and helps doctors track dangerous outbreaks faster than ever before
medRxiv
Apr 28, 2026
Infectious Disease
Review of genomic surveillance finds concurrent Mpox subclade circulation across Africa
Mpox Is Spreading in Ways Scientists Didn't See Coming
This review synthesizes genomic surveillance data from 24 African Union Member States, covering 3,450 high-quality MPXV virus whole genomes.…
Mpox is spreading across Africa in surprising ways, with different strains jumping from animals to people or spreading quietly between human…
medRxiv
Apr 18, 2026
Infectious Disease
Interim clinical treatment considerations for severe mpox manifestations in the United States
U.S. health officials review treatment options for severe mpox cases
A non-peer-reviewed report describes interim clinical treatment considerations for severe mpox manifestations in the United States. No study…
U.S. health officials are reviewing possible treatment approaches for severe mpox cases while more research is needed.
CDC
Apr 5, 2026
Infectious Disease
US report describes racial disparities in mpox incidence among adult males
Report describes racial disparities in mpox cases among adult males in the US
An observational report from the United States describes racial and ethnic disparities in mpox incidence among adult males. The report notes…
A new report shows non-Hispanic Black and Hispanic or Latino males in the US had different mpox infection rates compared to non-Hispanic whi…
CDC
Apr 5, 2026
Infectious Disease
Field report describes posttreatment lesions after tecovirimat therapy for mpox in New York City
What happens after mpox treatment? Doctors describe lingering skin lesions.
A field report from New York City describes posttreatment lesions in mpox patients who received tecovirimat. No sample size, comparator, or …
Doctors in New York City report that some mpox patients developed new skin lesions after finishing antiviral treatment.
CDC
Apr 5, 2026
Infectious Disease
Report describes shortfalls in mpox vaccination coverage among eligible persons in the US
Report describes shortfalls in mpox vaccination coverage among eligible people in the US
A report describes shortfalls in mpox vaccination coverage among vaccine-eligible persons in the United States. No study design, sample size…
A new report shows that many people in the United States who are eligible for the mpox vaccine have not yet received it.
CDC
Apr 5, 2026
Infectious Disease
Survey explores possible undetected mpox infection among people experiencing homelessness in San Francisco
Did mpox spread undetected among people experiencing homelessness?
A survey was conducted among people accessing homeless services or staying in encampments in San Francisco to explore possible undetected mp…
Health officials surveyed people experiencing homelessness to check for undetected mpox infections that might have spread in hard-to-see pla…
CDC
Apr 5, 2026
Infectious Disease
Observational analysis examines mpox cases in New York City
New York City health officials analyze mpox case data to track the outbreak
An observational analysis examined mpox cases in New York City. The study did not report specific results, outcomes, or safety data. This li…
New York City health officials analyzed mpox case data from the 2022 outbreak to better understand how the virus was spreading in the city.
CDC
Apr 5, 2026
Infectious Disease
Observational report describes mpox features in US adults aged 50+ versus younger adults
Health officials describe mpox features in older adults compared to younger adults
An observational report describes epidemiologic and clinical features of mpox in US adults aged 50 years and older compared to other adults,…
Health officials describe how mpox features in adults over 50 differ from younger adults and how JYNNEOS vaccination status compares.
CDC
Apr 5, 2026
Infectious Disease
JYNNEOS vaccine recipients characterized at Louisiana LGBTQIA+ festival
Who got the monkeypox vaccine at a major LGBTQIA+ festival in Louisiana?
A report described characteristics of JYNNEOS vaccine recipients before and during a large multiday LGBTQIA+ festival in Louisiana. No study…
A large monkeypox vaccination event took place at an LGBTQIA+ festival in Louisiana, offering a snapshot of who received the JYNNEOS vaccine…
CDC
Apr 5, 2026
Infectious Disease
Possible mpox exposures described in patients without reported male-to-male sexual contact
How are people getting mpox without male-to-male sexual contact?
An observational report from six U.S. jurisdictions described possible mpox exposures among patients who did not report male-to-male sexual …
Health officials are tracking mpox cases in people who didn't report male-to-male sexual contact to understand how the virus is spreading.
CDC
Apr 5, 2026
Infectious Disease
Mpox outbreak reported in Los Angeles County, California during summer 2023
What happened with mpox in Los Angeles last summer?
An outbreak report describes a mpox outbreak in Los Angeles County, California during summer 2023. Key details about the population, sample …
A new report confirms an mpox outbreak with a painful rash and flu-like symptoms occurred in Los Angeles County during the summer of 2023.
CDC
Apr 5, 2026